These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23558563)

  • 21. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?
    Moirand R; Mendler MH; Guillygomarc'h A; Brissot P; Deugnier Y
    J Hepatol; 2000 Dec; 33(6):1024-6. PubMed ID: 11131442
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis.
    Ucar F; Sezer S; Erdogan S; Akyol S; Armutcu F; Akyol O
    Redox Rep; 2013; 18(4):127-33. PubMed ID: 23743495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
    Handa P; Morgan-Stevenson V; Maliken BD; Nelson JE; Washington S; Westerman M; Yeh MM; Kowdley KV
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G117-27. PubMed ID: 26564716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholinesterase-independent protective effects of huperzine A against iron overload-induced oxidative damage and aberrant iron metabolism signaling in rat cortical neurons.
    Tao LX; Huang XT; Chen YT; Tang XC; Zhang HY
    Acta Pharmacol Sin; 2016 Nov; 37(11):1391-1400. PubMed ID: 27498774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-type calcium channel blockers decrease the iron overload-mediated oxidative stress in renal epithelial cells by reducing iron accumulation.
    Sun L; Lin X; Pornprasert S; Lü X; Ran B; Lin Y
    Eur J Pharmacol; 2020 Nov; 886():173513. PubMed ID: 32898550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of iron in hepatic inflammation and hepatocellular carcinoma.
    Miyanishi K; Tanaka S; Sakamoto H; Kato J
    Free Radic Biol Med; 2019 Mar; 133():200-205. PubMed ID: 30017991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload.
    Camiolo G; Tibullo D; Giallongo C; Romano A; Parrinello NL; Musumeci G; Di Rosa M; Vicario N; Brundo MV; Amenta F; Ferrante M; Copat C; Avola R; Li Volti G; Salvaggio A; Di Raimondo F; Palumbo GA
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron overload inhibits osteoblast biological activity through oxidative stress.
    He YF; Ma Y; Gao C; Zhao GY; Zhang LL; Li GF; Pan YZ; Li K; Xu YJ
    Biol Trace Elem Res; 2013 May; 152(2):292-6. PubMed ID: 23334864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action.
    Videla LA; Valenzuela R
    Biofactors; 2022 Mar; 48(2):400-415. PubMed ID: 34687092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Sodium Ferulate Supplementation Scavenges Oxygen Radicals and Reverses Liver Damage Induced by Iron Overloading.
    Qiao Y; He H; Zhang Z; Liao Z; Yin D; Liu D; Yi B; He M
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27649133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.
    Amorim R; Simões ICM; Veloso C; Carvalho A; Simões RF; Pereira FB; Thiel T; Normann A; Morais C; Jurado AS; Wieckowski MR; Teixeira J; Oliveira PJ
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine prevented high-fat diet-induced oxidative stress by activating AMPK and epigenetically modulating the expression of glutathione synthesis-related genes.
    Zhou X; He L; Zuo S; Zhang Y; Wan D; Long C; Huang P; Wu X; Wu C; Liu G; Yin Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):488-498. PubMed ID: 29158183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical evaluation of the role of iron overload in fatty liver disease.
    Fernandez M; Lokan J; Leung C; Grigg A
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1873-1883. PubMed ID: 35906772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis.
    Zhang J; Li Y; Jiang S; Yu H; An W
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C279-90. PubMed ID: 24284796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Etiopathogenesis of non-alcoholic steatohepatitis].
    Pérez-Aguilar F
    Gastroenterol Hepatol; 2005; 28(7):396-406. PubMed ID: 16137475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fargion S
    World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From fatty liver to fibrosis: a tale of "second hit".
    Basaranoglu M; Basaranoglu G; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1158-65. PubMed ID: 23483818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
    Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
    J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.